Global Vials for COVID-19 Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 47773
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Packaging
Buy @ $3500

The Vials for COVID-19 Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Vials for COVID-19 Vaccine size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Vials for COVID-19 Vaccine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Vials for COVID-19 Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Middle-borate Borosilicate Glass

Low-borate Borosilicate Glass

Market segment by Application can be divided into

Vaccine Manufacturing

Vaccine Researching

The key market players for global Vials for COVID-19 Vaccine market are listed below:

Corning

Schott AG

SiO2 Materials Science

SGD Pharma

Stevanato Group

DWK Life Sciences

Gerresheimer

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Vials for COVID-19 Vaccine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Vials for COVID-19 Vaccine, with price, sales, revenue and global market share of Vials for COVID-19 Vaccine in 2018 and 2019.

Chapter 3, the Vials for COVID-19 Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Vials for COVID-19 Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Vials for COVID-19 Vaccine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Vials for COVID-19 Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Vials for COVID-19 Vaccine Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Vials for COVID-19 Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Middle-borate Borosilicate Glass

1.2.3 Low-borate Borosilicate Glass

1.3 Market Analysis by Application

1.3.1 Overview: Global Vials for COVID-19 Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Vaccine Manufacturing

1.3.3 Vaccine Researching

1.4 Global Vials for COVID-19 Vaccine Market Size & Forecast

1.4.1 Global Vials for COVID-19 Vaccine Sales in Value (2016-2026))

1.4.2 Global Vials for COVID-19 Vaccine Sales in Volume (2016-2026)

1.4.3 Global Vials for COVID-19 Vaccine Price by Type (2016-2026) & (US$/K Units)

1.5 Global Vials for COVID-19 Vaccine Production Capacity Analysis

1.5.1 Global Vials for COVID-19 Vaccine Total Production Capacity (2016-2026)

1.5.2 Global Vials for COVID-19 Vaccine Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Vials for COVID-19 Vaccine Market Drivers

1.6.2 Vials for COVID-19 Vaccine Market Restraints

1.6.3 Vials for COVID-19 Vaccine Trends Analysis

2 Manufacturers Profiles

2.1 Corning

2.1.1 Corning Details

2.1.2 Corning Major Business

2.1.3 Corning Vials for COVID-19 Vaccine Product and Services

2.1.4 Corning Vials for COVID-19 Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 Schott AG

2.2.1 Schott AG Details

2.2.2 Schott AG Major Business

2.2.3 Schott AG Vials for COVID-19 Vaccine Product and Services

2.2.4 Schott AG Vials for COVID-19 Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 SiO2 Materials Science

2.3.1 SiO2 Materials Science Details

2.3.2 SiO2 Materials Science Major Business

2.3.3 SiO2 Materials Science Vials for COVID-19 Vaccine Product and Services

2.3.4 SiO2 Materials Science Vials for COVID-19 Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 SGD Pharma

2.4.1 SGD Pharma Details

2.4.2 SGD Pharma Major Business

2.4.3 SGD Pharma Vials for COVID-19 Vaccine Product and Services

2.4.4 SGD Pharma Vials for COVID-19 Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Stevanato Group

2.5.1 Stevanato Group Details

2.5.2 Stevanato Group Major Business

2.5.3 Stevanato Group Vials for COVID-19 Vaccine Product and Services

2.5.4 Stevanato Group Vials for COVID-19 Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 DWK Life Sciences

2.6.1 DWK Life Sciences Details

2.6.2 DWK Life Sciences Major Business

2.6.3 DWK Life Sciences Vials for COVID-19 Vaccine Product and Services

2.6.4 DWK Life Sciences Vials for COVID-19 Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Gerresheimer

2.7.1 Gerresheimer Details

2.7.2 Gerresheimer Major Business

2.7.3 Gerresheimer Vials for COVID-19 Vaccine Product and Services

2.7.4 Gerresheimer Vials for COVID-19 Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Vials for COVID-19 Vaccine Sales by Manufacturer

3.1 Global Vials for COVID-19 Vaccine Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Vials for COVID-19 Vaccine Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Vials for COVID-19 Vaccine

3.4 Market Concentration Rate

3.4.1 Top 3 Vials for COVID-19 Vaccine Manufacturer Market Share

3.4.2 Top 6 Vials for COVID-19 Vaccine Manufacturer Market Share

3.5 Global Vials for COVID-19 Vaccine Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Vials for COVID-19 Vaccine Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Vials for COVID-19 Vaccine Market Size by Region

4.1.1 Global Vials for COVID-19 Vaccine Sales in Volume by Region (2016-2026)

4.1.2 Global Vials for COVID-19 Vaccine Revenue by Region (2016-2026)

4.2 North America Vials for COVID-19 Vaccine Revenue (2016-2026)

4.3 Europe Vials for COVID-19 Vaccine Revenue (2016-2026)

4.4 Asia-Pacific Vials for COVID-19 Vaccine Revenue (2016-2026)

4.5 South America Vials for COVID-19 Vaccine Revenue (2016-2026)

4.6 Middle East and Africa Vials for COVID-19 Vaccine Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Vials for COVID-19 Vaccine Sales in Volume by Type (2016-2026)

5.2 Global Vials for COVID-19 Vaccine Revenue by Type (2016-2026)

5.3 Global Vials for COVID-19 Vaccine Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Vials for COVID-19 Vaccine Sales in Volume by Application (2016-2026)

6.2 Global Vials for COVID-19 Vaccine Revenue by Application (2016-2026)

6.3 Global Vials for COVID-19 Vaccine Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Vials for COVID-19 Vaccine Sales by Type (2016-2026)

7.2 North America Vials for COVID-19 Vaccine Sales by Application (2016-2026)

7.3 North America Vials for COVID-19 Vaccine Market Size by Country

7.3.1 North America Vials for COVID-19 Vaccine Sales in Volume by Country (2016-2026)

7.3.2 North America Vials for COVID-19 Vaccine Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Vials for COVID-19 Vaccine Sales by Type (2016-2026)

8.2 Europe Vials for COVID-19 Vaccine Sales by Application (2016-2026)

8.3 Europe Vials for COVID-19 Vaccine Market Size by Country

8.3.1 Europe Vials for COVID-19 Vaccine Sales in Volume by Country (2016-2026)

8.3.2 Europe Vials for COVID-19 Vaccine Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Vials for COVID-19 Vaccine Sales by Type (2016-2026)

9.2 Asia-Pacific Vials for COVID-19 Vaccine Sales by Application (2016-2026)

9.3 Asia-Pacific Vials for COVID-19 Vaccine Market Size by Region

9.3.1 Asia-Pacific Vials for COVID-19 Vaccine Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Vials for COVID-19 Vaccine Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Vials for COVID-19 Vaccine Sales by Type (2016-2026)

10.2 South America Vials for COVID-19 Vaccine Sales by Application (2016-2026)

10.3 South America Vials for COVID-19 Vaccine Market Size by Country

10.3.1 South America Vials for COVID-19 Vaccine Sales in Volume by Country (2016-2026)

10.3.2 South America Vials for COVID-19 Vaccine Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Vials for COVID-19 Vaccine Sales by Type (2016-2026)

11.2 Middle East & Africa Vials for COVID-19 Vaccine Sales by Application (2016-2026)

11.3 Middle East & Africa Vials for COVID-19 Vaccine Market Size by Country

11.3.1 Middle East & Africa Vials for COVID-19 Vaccine Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Vials for COVID-19 Vaccine Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Vials for COVID-19 Vaccine Typical Distributors

12.3 Vials for COVID-19 Vaccine Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

12.1.2 Indirect Marketing

12.2 Vials for COVID-19 Vaccine Typical Distributors

12.3 Vials for COVID-19 Vaccine Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Vials for COVID-19 Vaccine Revenue by Type, (USD Million), 2021-2026

Table 2. Global Vials for COVID-19 Vaccine Revenue by Application, (USD Million), 2021-2026

Table 3. Corning Basic Information, Manufacturing Base and Competitors

Table 4. Corning Major Business

Table 5. Corning Vials for COVID-19 Vaccine Product and Services

Table 6. Corning Vials for COVID-19 Vaccine Sales (Million Units), Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Schott AG Basic Information, Manufacturing Base and Competitors

Table 8. Schott AG Major Business

Table 9. Schott AG Vials for COVID-19 Vaccine Product and Services

Table 10. Schott AG Vials for COVID-19 Vaccine Sales (Million Units), Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. SiO2 Materials Science Basic Information, Manufacturing Base and Competitors

Table 12. SiO2 Materials Science Major Business

Table 13. SiO2 Materials Science Vials for COVID-19 Vaccine Product and Services

Table 14. SiO2 Materials Science Vials for COVID-19 Vaccine Sales (Million Units), Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. SGD Pharma Basic Information, Manufacturing Base and Competitors

Table 16. SGD Pharma Major Business

Table 17. SGD Pharma Vials for COVID-19 Vaccine Product and Services

Table 18. SGD Pharma Vials for COVID-19 Vaccine Sales (Million Units), Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Stevanato Group Basic Information, Manufacturing Base and Competitors

Table 20. Stevanato Group Major Business

Table 21. Stevanato Group Vials for COVID-19 Vaccine Product and Services

Table 22. Stevanato Group Vials for COVID-19 Vaccine Sales (Million Units), Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. DWK Life Sciences Basic Information, Manufacturing Base and Competitors

Table 24. DWK Life Sciences Major Business

Table 25. DWK Life Sciences Vials for COVID-19 Vaccine Product and Services

Table 26. DWK Life Sciences Vials for COVID-19 Vaccine Sales (Million Units), Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Gerresheimer Basic Information, Manufacturing Base and Competitors

Table 28. Gerresheimer Major Business

Table 29. Gerresheimer Vials for COVID-19 Vaccine Product and Services

Table 30. Gerresheimer Vials for COVID-19 Vaccine Sales (Million Units), Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Global Vials for COVID-19 Vaccine Sales by Manufacturer (2019-2021e) & (Million Units)

Table 32. Global Vials for COVID-19 Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 33. Market Position of Manufacturers in Vials for COVID-19 Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 34. Global Vials for COVID-19 Vaccine Production Capacity by Company, (Million Units): 2020 VS 2021

Table 35. Head Office and Vials for COVID-19 Vaccine Production Site of Key Manufacturer

Table 36. Vials for COVID-19 Vaccine New Entrant and Capacity Expansion Plans

Table 37. Vials for COVID-19 Vaccine Mergers & Acquisitions in the Past Five Years

Table 38. Global Vials for COVID-19 Vaccine Sales by Region (2016-2021e) & (Million Units)

Table 39. Global Vials for COVID-19 Vaccine Sales by Region (2021-2026) & (Million Units)

Table 40. Global Vials for COVID-19 Vaccine Revenue by Region (2016-2021e) & (USD Million)

Table 41. Global Vials for COVID-19 Vaccine Revenue by Region (2021-2026) & (USD Million)

Table 42. Global Vials for COVID-19 Vaccine Sales by Type (2016-2021e) & (Million Units)

Table 43. Global Vials for COVID-19 Vaccine Sales by Type (2021-2026) & (Million Units)

Table 44. Global Vials for COVID-19 Vaccine Revenue by Type (2016-2021e) & (USD Million)

Table 45. Global Vials for COVID-19 Vaccine Revenue by Type (2021-2026) & (USD Million)

Table 46. Global Vials for COVID-19 Vaccine Price by Type (2016-2021e) & (US$/K Units)

Table 47. Global Vials for COVID-19 Vaccine Price by Type (2021-2026) & (US$/K Units)

Table 48. Global Vials for COVID-19 Vaccine Sales by Application (2016-2021e) & (Million Units)

Table 49. Global Vials for COVID-19 Vaccine Sales by Application (2021-2026) & (Million Units)

Table 50. Global Vials for COVID-19 Vaccine Revenue by Application (2016-2021e) & (USD Million)

Table 51. Global Vials for COVID-19 Vaccine Revenue by Application (2021-2026) & (USD Million)

Table 52. Global Vials for COVID-19 Vaccine Price by Application (2016-2021e) & (US$/K Units)

Table 53. Global Vials for COVID-19 Vaccine Price by Application (2021-2026) & (US$/K Units)

Table 54. North America Vials for COVID-19 Vaccine Sales by Country (2016-2021e) & (Million Units)

Table 55. North America Vials for COVID-19 Vaccine Sales by Country (2021-2026) & (Million Units)

Table 56. North America Vials for COVID-19 Vaccine Revenue by Country (2016-2021e) & (USD Million)

Table 57. North America Vials for COVID-19 Vaccine Revenue by Country (2021-2026) & (USD Million)

Table 58. North America Vials for COVID-19 Vaccine Sales by Type (2016-2021e) & (Million Units)

Table 59. North America Vials for COVID-19 Vaccine Sales by Type (2021-2026) & (Million Units)

Table 60. North America Vials for COVID-19 Vaccine Sales by Application (2016-2021e) & (Million Units)

Table 61. North America Vials for COVID-19 Vaccine Sales by Application (2021-2026) & (Million Units)

Table 62. Europe Vials for COVID-19 Vaccine Sales by Country (2016-2021e) & (Million Units)

Table 63. Europe Vials for COVID-19 Vaccine Sales by Country (2021-2026) & (Million Units)

Table 64. Europe Vials for COVID-19 Vaccine Revenue by Country (2016-2021e) & (USD Million)

Table 65. Europe Vials for COVID-19 Vaccine Revenue by Country (2021-2026) & (USD Million)

Table 66. Europe Vials for COVID-19 Vaccine Sales by Type (2016-2021e) & (Million Units)

Table 67. Europe Vials for COVID-19 Vaccine Sales by Type (2021-2026) & (Million Units)

Table 68. Europe Vials for COVID-19 Vaccine Sales by Application (2016-2021e) & (Million Units)

Table 69. Europe Vials for COVID-19 Vaccine Sales by Application (2021-2026) & (Million Units)

Table 70. Asia-Pacific Vials for COVID-19 Vaccine Sales by Region (2016-2021e) & (Million Units)

Table 71. Asia-Pacific Vials for COVID-19 Vaccine Sales by Region (2021-2026) & (Million Units)

Table 72. Asia-Pacific Vials for COVID-19 Vaccine Revenue by Region (2016-2021e) & (USD Million)

Table 73. Asia-Pacific Vials for COVID-19 Vaccine Revenue by Region (2021-2026) & (USD Million)

Table 74. Asia-Pacific Vials for COVID-19 Vaccine Sales by Type (2016-2021e) & (Million Units)

Table 75. Asia-Pacific Vials for COVID-19 Vaccine Sales by Type (2021-2026) & (Million Units)

Table 76. Asia-Pacific Vials for COVID-19 Vaccine Sales by Application (2016-2021e) & (Million Units)

Table 77. Asia-Pacific Vials for COVID-19 Vaccine Sales by Application (2021-2026) & (Million Units)

Table 78. South America Vials for COVID-19 Vaccine Sales by Country (2016-2021e) & (Million Units)

Table 79. South America Vials for COVID-19 Vaccine Sales by Country (2021-2026) & (Million Units)

Table 80. South America Vials for COVID-19 Vaccine Revenue by Country (2016-2021e) & (USD Million)

Table 81. South America Vials for COVID-19 Vaccine Revenue by Country (2021-2026) & (USD Million)

Table 82. South America Vials for COVID-19 Vaccine Sales by Type (2016-2021e) & (Million Units)

Table 83. South America Vials for COVID-19 Vaccine Sales by Type (2021-2026) & (Million Units)

Table 84. South America Vials for COVID-19 Vaccine Sales by Application (2016-2021e) & (Million Units)

Table 85. South America Vials for COVID-19 Vaccine Sales by Application (2021-2026) & (Million Units)

Table 86. Middle East & Africa Vials for COVID-19 Vaccine Sales by Country (2016-2021e) & (Million Units)

Table 87. Middle East & Africa Vials for COVID-19 Vaccine Sales by Country (2021-2026) & (Million Units)

Table 88. Middle East & Africa Vials for COVID-19 Vaccine Revenue by Country (2016-2021e) & (USD Million)

Table 89. Middle East & Africa Vials for COVID-19 Vaccine Revenue by Country (2021-2026) & (USD Million)

Table 90. Middle East & Africa Vials for COVID-19 Vaccine Sales by Type (2016-2021e) & (Million Units)

Table 91. Middle East & Africa Vials for COVID-19 Vaccine Sales by Type (2021-2026) & (Million Units)

Table 92. Middle East & Africa Vials for COVID-19 Vaccine Sales by Application (2016-2021e) & (Million Units)

Table 93. Middle East & Africa Vials for COVID-19 Vaccine Sales by Application (2021-2026) & (Million Units)

Table 94. Direct Channel Pros & Cons

Table 95. Indirect Channel Pros & Cons

Table 96. Vials for COVID-19 Vaccine Typical Distributors

Table 97. Vials for COVID-19 Vaccine Typical Customers

List of Figures

Figure 1. Vials for COVID-19 Vaccine Picture

Figure 2. Global Vials for COVID-19 Vaccine Sales Market Share by Type in 2020

Figure 3. Middle-borate Borosilicate Glass

Figure 4. Low-borate Borosilicate Glass

Figure 5. Global Vials for COVID-19 Vaccine Sales Market Share by Application in 2020

Figure 6. Vaccine Manufacturing

Figure 7. Vaccine Researching

Figure 8. Global Vials for COVID-19 Vaccine Market Size, (USD Million) & (Million Units): 2020 VS 2021 VS 2026

Figure 9. Global Vials for COVID-19 Vaccine Market Size and Forecast (2016-2026) & (USD Million)

Figure 10. Global Vials for COVID-19 Vaccine Sales (2016-2026) & (Million Units)

Figure 11. Global Vials for COVID-19 Vaccine Price by Type (2016-2026) & (US$/K Units)

Figure 12. Global Vials for COVID-19 Vaccine Production Capacity (2016-2026) & (Million Units)

Figure 13. Global Vials for COVID-19 Vaccine Production Capacity by Geographic Region: 2020 VS 2021

Figure 14. Vials for COVID-19 Vaccine Market Drivers

Figure 15. Vials for COVID-19 Vaccine Market Restraints

Figure 16. Vials for COVID-19 Vaccine Market Trends

Figure 17. Global Vials for COVID-19 Vaccine Sales Market Share by Manufacturer in 2020

Figure 18. Global Vials for COVID-19 Vaccine Revenue Market Share by Manufacturer in 2020

Figure 19. Vials for COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. Top 3 Vials for COVID-19 Vaccine Manufacturer (Revenue) Market Share in 2020

Figure 21. Top 6 Vials for COVID-19 Vaccine Manufacturer (Revenue) Market Share in 2020

Figure 22. Global Vials for COVID-19 Vaccine Sales Market Share by Region (2016-2026)

Figure 23. Global Vials for COVID-19 Vaccine Revenue Market Share by Region (2016-2026)

Figure 24. North America Vials for COVID-19 Vaccine Revenue (2016-2026) & (USD Million)

Figure 25. Europe Vials for COVID-19 Vaccine Revenue (2016-2026) & (USD Million)

Figure 26. Asia-Pacific Vials for COVID-19 Vaccine Revenue (2016-2026) & (USD Million)

Figure 27. South America Vials for COVID-19 Vaccine Revenue (2016-2026) & (USD Million)

Figure 28. Middle East & Africa Vials for COVID-19 Vaccine Revenue (2016-2026) & (USD Million)

Figure 29. Global Vials for COVID-19 Vaccine Sales Market Share by Type (2016-2026)

Figure 30. Global Vials for COVID-19 Vaccine Revenue Market Share by Type (2016-2026)

Figure 31. Global Vials for COVID-19 Vaccine Price by Type (2016-2026) & (US$/K Units)

Figure 32. Global Vials for COVID-19 Vaccine Sales Market Share by Application (2016-2026)

Figure 33. Global Vials for COVID-19 Vaccine Revenue Market Share by Application (2016-2026)

Figure 34. Global Vials for COVID-19 Vaccine Price by Application (2016-2026) & (US$/K Units)

Figure 35. North America Vials for COVID-19 Vaccine Sales Market Share by Type (2016-2026)

Figure 36. North America Vials for COVID-19 Vaccine Sales Market Share by Application (2016-2026)

Figure 37. North America Vials for COVID-19 Vaccine Sales Market Share by Country (2016-2026)

Figure 38. North America Vials for COVID-19 Vaccine Revenue Market Share by Country (2016-2026)

Figure 39. United States Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 40. Canada Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Mexico Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Europe Vials for COVID-19 Vaccine Sales Market Share by Type (2016-2026)

Figure 43. Europe Vials for COVID-19 Vaccine Sales Market Share by Application (2016-2026)

Figure 44. Europe Vials for COVID-19 Vaccine Sales Market Share by Country (2016-2026)

Figure 45. Europe Vials for COVID-19 Vaccine Revenue Market Share by Country (2016-2026)

Figure 46. Germany Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. France Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. United Kingdom Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Russia Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Italy Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Asia-Pacific Vials for COVID-19 Vaccine Sales Market Share by Region (2016-2026)

Figure 52. Asia-Pacific Vials for COVID-19 Vaccine Sales Market Share by Application (2016-2026)

Figure 53. Asia-Pacific Vials for COVID-19 Vaccine Sales Market Share by Region (2016-2026)

Figure 54. Asia-Pacific Vials for COVID-19 Vaccine Revenue Market Share by Region (2016-2026)

Figure 55. China Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Japan Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Korea Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. India Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Southeast Asia Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Australia Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. South America Vials for COVID-19 Vaccine Sales Market Share by Type (2016-2026)

Figure 62. South America Vials for COVID-19 Vaccine Sales Market Share by Application (2016-2026)

Figure 63. South America Vials for COVID-19 Vaccine Sales Market Share by Country (2016-2026)

Figure 64. South America Vials for COVID-19 Vaccine Revenue Market Share by Country (2016-2026)

Figure 65. Brazil Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Argentina Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Middle East & Africa Vials for COVID-19 Vaccine Sales Market Share by Type (2016-2026)

Figure 68. Middle East & Africa Vials for COVID-19 Vaccine Sales Market Share by Application (2016-2026)

Figure 69. Middle East & Africa Vials for COVID-19 Vaccine Sales Market Share by Country (2016-2026)

Figure 70. Middle East & Africa Vials for COVID-19 Vaccine Revenue Market Share by Country (2016-2026)

Figure 71. Turkey Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Egypt Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Saudi Arabia Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. South Africa Vials for COVID-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Sales Channel: Direct Channel vs Indirect Channel

Figure 76. Methodology

Figure 77. Research Process and Data Source